GlassScriptPhysician profile
Timothy S Houden
NPI 1255339552
$1,267.54
in general payments reported to CMS, 2019-2025
19 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $296 · 2021: $152 · 2022: $112 · 2023: $138 · 2024: $43.78 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $386.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $287.10 | 2020-2023 | Senza |
| Relievant Medsystems, INC. | $166.75 | 2019-2022 | |
| Boston Scientific Corporation | $130.36 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $92.75 | 2021-2023 | Intellis Adaptivestim |
| Avanos Medical | $84.22 | 2019-2025 | Standard Rf Disposables |
| Abbott Laboratories | $78.64 | 2020-2023 | Proclaim |
| Merz Pharmaceuticals, LLC | $71.08 | 2022-2025 | Xeomin |
| Saluda Medical Americas, INC. | $64.29 | 2025 | Evoke |
| Pfizer INC. | $43.18 | 2019 | |
| Chiesi USA, INC. | $38.36 | 2021-2025 | Cleviprex |
| Pacira Pharmaceuticals Incorporated | $33.33 | 2021 | |
| Saol Therapeutics INC. | $32.25 | 2020 | |
| Medtronic USA, INC. | $26.05 | 2019-2020 | |
| Nalu Medical, INC. | $25.97 | 2021 | |
| Ethicon US, LLC | $25.71 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $24.68 | 2024 | Qutenza |
| Merck Sharp & Dohme LLC | $19.69 | 2021 | |
| Scilex Pharmaceuticals INC. | $12.23 | 2019 | |
| Spr Therapeutics, INC | $10.90 | 2025 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Houden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.